Gateway Investment Advisers LLC Moderna, Inc. Transaction History

Gateway Investment Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$96.41 - $126.61 $1.97 Million - $2.59 Million	-20,475 Reduced 25.94%	58,445 $6.04 Million
Q2 2023 Jul 13, 2023	SELL	$118.5 - $160.53 $298,620 - $404,535	-2,520 Reduced 3.09%	78,920 $9.59 Million
Q1 2023 Apr 11, 2023	SELL	$135.66 - $197.02 $2.2 Million - $3.19 Million	-16,187 Reduced 16.58%	81,440 $12.5 Million
Q4 2022 Jan 13, 2023	SELL	$118.38 - $210.04 $28,884 - $51,249	-244 Reduced 0.25%	97,627 $0
Q3 2022 Oct 07, 2022	SELL	$118.07 - $194.18 $1.67 Million - $2.75 Million	-14,182 Reduced 12.66%	97,871 $11.6 Million
Q2 2022 Jul 13, 2022	BUY	$117.13 - $176.59 $10.7 Million - $16.1 Million	91,044 Added 433.36%	112,053 $16 Million
Q1 2022 Apr 14, 2022	SELL	$126.46 - $235.05 $7.61 Million - $14.2 Million	-60,204 Reduced 74.13%	21,009 $3.62 Million
Q4 2021 Jan 14, 2022	BUY	$225.82 - $368.51 $9.44 Million - $15.4 Million	41,794 Added 106.03%	81,213 $20.6 Million
Q3 2021 Oct 22, 2021	BUY	$221.9 - $484.47 $8.75 Million - $19.1 Million	39,419 New	39,419 $15.2 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Gateway Investment Advisers LLC with notifications on news.